300 years of genomics experience?! Parexel sets up ex GSK staff gene team
Parexel has set up a team of ex-GSK genomics experts in response to growing sponsor demand for “precision medicine” development knowhow.
Archives for February 17, 2016
Suppliers announce alliance to support manufacturers
Suppliers have created the Matrix Alliance, as next-generation drugs will require agile manufacturing processes and packaging solutions.
Alnylam lays down plans for commercial RNAi manufacturing plant
Alnylam has acquired 12 acres of land in Massachusetts in anticipation of building a manufacturing facility for its RNA interference therapies.
‘Four years, or less,’ for Zika therapeutic, says Ennaid CEO
Ennaid Therapeutics has announced it is developing therapeutic cures to help those that may become infected with the Zika Virus, and it may be available in less than four years.
EMA advocates more regular MRIs for MS patients on Biogen’s mAb Tysabri
Multiple sclerosis patients taking Tysabri (natalizumab) who are deemed to be at high risk for the lethal infection PML should have regular brain scans according to the EMA.
Co-locating trial and commercial manufacturing eases tech transfer and cuts cycle times, Aesica
Moving its clinical manufacturing operations to its API and drug site in Queenborough has reduced the risk of problems during tech transfer and cut cycle times according to UK CMO Aesica.
Symbiosis growing on aseptic demand from US biotech
A robust investment environment and high quality demands have driven US biotech business to UK-based sterile manufacturer Symbiosis, the firm says.